The appointment of FDA Deputy Associate Commissioner for Regulatory Affairs Howard Sklamberg as the Center for Drug Evaluation and Research’s new compliance head gives the Office of Compliance permanent leadership in the midst of ongoing fallout from the pharmacy compounding-related meningitis outbreak.
Sklamberg, who is expected to assume the position as Office of Compliance director on Jan. 14, brings experience dealing with...